Comments

MiMedx Group

Q: What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MDXGNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$9.16

-0.32-3.38%

Pre-Market: 7:48 PM EDT

MiMedx Group (MDXG) Forecast

News Earnings MiMedx Group (MDXG) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Overview Rating

Good

Technicals Analysis

100

0100

Financials Analysis

0100

MiMedx Group (NASDAQ:MDXG) Stock Quotes, Forecast and News Summary

MiMedx Group Stock (NASDAQ: MDXG) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 768.53K
Day Range	- - -
52 Wk Range	5.47 - 10.14
Market Cap	$1.35B
P/E Ratio	16.63
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.27%
Days to Cover	4.8

Recent News

Analyst Bullish On MiMedx's Rapid Growth In $4B Woundcare Market With Innovative Skin Substitutes

Cantor Fitzgerald has initiated coverage on MIMEDX, highlighting its strong market presence in wound care and surgical recovery. Targeting a $3.9 billion market, MIMEDX products demonstrate a 97% wound closure rate for diabetic foot ulcers, cost-effectiveness, and significant growth potential.

Vandana Singh

Rivian Automotive Reports Weak Delivery Figures, Joins JOYY, MiMedx Group And Other Big Stocks Moving Lower On Tuesday

U.S. stocks traded mostly lower, with the Nasdaq Composite falling around 200 points on Tuesday.

Avi Kapoor

Chipotle, Amazon, Deckers Outdoor, Capital One And Other Stocks Move Higher On Friday

U.S. stocks traded mixed, with the Nasdaq Composite gaining more than 100 points on Friday. Here are some big stocks recording gains in today’s session.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 768.53K
Day Range	- - -
52 Wk Range	5.47 - 10.14
Market Cap	$1.35B
P/E Ratio	16.63
Dividend Yield	-
Exchange	NASDAQ
RSI	47
Short Interest	3.27%
Days to Cover	4.8

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MiMedx Group (MDXG) stock?

You can purchase shares of MiMedx Group (NASDAQ:MDXG) through any online brokerage.

View our list of the best stock brokerages

Who are MiMedx Group (MDXG) competitors?

Other companies in MiMedx Group’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX), Arcutis Biotherapeutics (NASDAQ:ARQT) and Day One Biopharmaceutical (NASDAQ:DAWN).

What is the forecast, or price target, for MiMedx Group (MDXG) stock?

MiMedx Group has a consensus price target of $12.00.

What is the current price for MiMedx Group (MDXG)?

The stock price for MiMedx Group (NASDAQ: MDXG) is $9.16 last updated December 30, 2024 at 7:48 PM EST.

Does MiMedx Group (MDXG) pay a dividend?

There are no upcoming dividends for MiMedx Group.

When is MiMedx Group (NASDAQ:MDXG) reporting earnings?

MiMedx Group’s Q4 earnings are confirmed for Wednesday, February 26, 2025.

Is MiMedx Group (MDXG) going to split?

There is no upcoming split for MiMedx Group.

What sector and industry does MiMedx Group (MDXG) operate in?

MiMedx Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.